Searched for
RUNJHUN JAIN
Gland Pharma up 40% in 2 days, but nobody can explain this sudden interestRunjhun Jain, a pharma analyst from Nirmal Bang, said the surge could only be a short-term phenomenon. That said, it is a good company for ...24 Nov, 2020, 10.54 AM IST- Smallcap pick of Kedia, Kacholia doubled money in last six monthsThe change in business strategy helped the stock rally over 135 per cent in last six months to trade at Rs 1,880 on September 30. Analysts ...01 Oct, 2020, 11.58 AM IST
- API makers surge up to 110% in 50 days as virus hits Chinese exportsBrokerage sees coronavirus crisis as a positive for companies like Granules India and Natco.20 Feb, 2020, 12.15 PM IST
- Dishman Pharma zooms 20% as merger with arms becomes effectiveFollowing the announcement, the stock hit its upper circuit limit of 20 per cent at Rs 278.20 on BSE.28 Mar, 2017, 10.21 AM IST
- Splendid show: Hrudayalaya rises 35% on listing; good long-term betNarayana Hrudayalaya, the first debutant of Calendar 2016 in the stock market, got off to a splendid start on Wednesday.06 Jan, 2016, 04.40 PM IST
- Maturing business, low attrition make Narayana Hrudayalaya a good long-term bet: Runjhun JainNarayana's hospitals, which are maturing or which are more than five years old, have Ebitda margins as high as 24%, says Jain.06 Jan, 2016, 12.58 PM IST
- Man behind Vodafone's Zoozoo & PugFor clients such as Vodafone - for whom Rao played a key role in creating the Zoozoos and the “pug ads” - he’s their 'Michelangelo'.28 Oct, 2009, 02.31 AM IST
Load More
